New inhaler aims to quiet chronic cough in clinical trial
Symptom relief
Recruiting now
This study tests an experimental inhaler called taplucainium (NOC-110) for adults who have had a chronic cough for at least a year with no clear cause or that doesn't respond to treatment. About 455 participants will receive either the drug or a placebo daily. The main goal is to…
Phase: PHASE2 • Sponsor: Nocion Therapeutics • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC